Luis Jódar

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

Eric J. Haas, Frederick J. Angulo, John M. McLaughlin et al. · The Lancet · 2021 · 1.7K citations · Full text

Vaccination, Vaccine Safety, Nationwide Vaccination Campaign +9

Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study

Sara Y. Tartof, Jeff Slezak, Heidi Fischer et al. · The Lancet · 2021 · 1.3K citations · Full text

Vaccination, Vaccine Safety, Retrospective Cohort Study +6

<i>Salmonella</i>Paratyphi A Rates, Asia

R. Leon Ochiai, Xuanyi Wang, Lorenz von Seidlein et al. · Emerging infectious diseases · 2005 · 187 citations · Full text

Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: a prospective cohort study in Bristol, United Kingdom

Catherine Hyams, Robert Challen, Robin Marlow et al. · The Lancet Regional Health - Europe · 2022 · 168 citations · Full text

Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine Against Hospitalization for Community-Acquired Pneumonia in Older US Adults: A Test-Negative Design

John M. McLaughlin, Qin Jiang, Raúl Istúriz et al. · Clinical Infectious Diseases · 2018 · 155 citations · Full text